Making the Switch: New Data for Improving Outcomes With Mixed-Oil TPN Formulation in ICU Patients

Speakers discuss new data for improved outcomes with use of next-generation, new parenteral nutrition (PN) lipid formulations. Speakers present new evidence for outcome benefits, including reduced complications and reduced length of stay in both adult and pediatric critically ill patients. These data, from a large institutional outcomes study in both adult and pediatric ICU patients, provide compelling evidence on the benefits of switching to a new PN lipid formulation in your hospital. The rationale, pathways, and key evidence needed for justifying the switch to a new PN lipid to improve outcomes in your institution are covered so you have the key data and support you need to “make the switch” now at your hospital!

SCCM offers various sponsorship and advertising opportunities for industry partners to promote their brand launches or current therapies, conduct a focused program on disease awareness, or discuss their current pipeline activity.

The views and opinions expressed are those of the sponsor and do not necessarily reflect the views or opinions of SCCM. References to specific commercial entities, products, tests, procedures, opinions, resources, and information do not reflect SCCM’s review or endorsement.